Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and malonic acid

n-methyl-3,4-methylenedioxyamphetamine has been researched along with malonic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burrows, KB; Gudelsky, GA; Nixdorf, WL; Yamamoto, BK1
Darvesh, AS; Gudelsky, GA; Yamamoto, BK1
Darvesh, AS; Gudelsky, GA1
Aguirre, N; Goñi-Allo, B; Herv'as, I; Lasheras, B; Ramos, M1
Hayat, S; Rattray, M; Williams, RJ1

Other Studies

5 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and malonic acid

ArticleYear
Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate.
    Journal of neurochemistry, 2001, Volume: 77, Issue:2

    Topics: Animals; Corpus Striatum; Dopamine; Drug Synergism; Energy Metabolism; Enzyme Inhibitors; Extracellular Space; Male; Malonates; Microdialysis; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Succinate Dehydrogenase

2001
Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:2

    Topics: Animals; Brain Chemistry; Citrulline; Dopamine; Enzyme Inhibitors; Fever; Male; Malonates; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Peroxynitrous Acid; Rats; Serotonin; Serotonin Agents; Thiourea; Tyrosine

2005
Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
    Brain research, 2005, Sep-21, Volume: 1056, Issue:2

    Topics: Adenosine Triphosphate; Animals; Brain; Brain Chemistry; Dopamine; Drug Interactions; Energy Metabolism; Male; Malonates; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Niacinamide; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Time Factors; Ubiquinone

2005
Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:2

    Topics: Amphetamine-Related Disorders; Animals; Body Temperature Regulation; Cell Survival; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Hallucinogens; Male; Malonates; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Piperazines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents

2006
Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:2

    Topics: Animals; Cell Line; Cell Survival; Chlorocebus aethiops; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Hallucinogens; Malonates; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Rats; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Transfection

2006